Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2016 Aug 2;22(11):2019–2024. doi: 10.1016/j.bbmt.2016.07.019

Table 5. Proportion of Patient Cohort with >80% Donor Myeloid Chimerism by UCB Unit–Recipient ABO Compatibility.

All (n = 268) ABO Match (n = 93) Major Mismatch (n = 72) Minor Mismatch (n = 80) Bidirectional Mismatch (n = 23) P
At day 100 (95% CI) 70% (63-75) 69% (58-79) 66% (54-78) 70% (60-81) 75% (56-94) .89
At last contact (95% CI) 74% (69-79) 79% (71-87) 66% (55-77) 75% (65-84) 74% (56-92) .33